TSN 0.00% 1.0¢ the sustainable nutrition group ltd

Arc - You can't compare the phase-II and -III like that. The...

  1. 483 Posts.
    lightbulb Created with Sketch. 60
    Arc - You can't compare the phase-II and -III like that.

    The phase-II was an open label study with all the biases that come along with knowledge of who is on the experimental therapy. This impacts both patients and clinicians. The phase-III was double blind and is therefore better controlled for biases.

    The phase-III readout is a much more reliable indicator of efficacy than the phase-II.
 
watchlist Created with Sketch. Add TSN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.